Articles On Holista CollTech (ASX:HCT)
| Title | Source | Codes | Date |
|---|---|---|---|
|
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July The Covid-19 pandemic had produced windfalls for and attracted fa... |
Stockhead | HCT | 2 years ago |
|
Closing Bell: ASX 200 trades flat on tepid start to week, but Mantle Minerals shines
ASX chopped about sideways, losing any slight semblance of fizz at close: -0.063% IT, Discretionary and Industrials led sectors, while Materials lagged The day’s clear winner was Mantle Minerals, up 50% at day’s end on further exploration... |
Stockhead | HCT | 2 years ago |
|
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month The world is anticipating a “game changer” as Brisba... |
Stockhead | HCT | 2 years ago |
|
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | HCT | 2 years ago |
|
Closing Bell: Its another win for the ASX on Friday as Austral nabs US$3 billion US Navy deal
S&P/ASX 200 closes up 0.6%, while the emerging companies index rises 0.86% Austral’s US subsidiary Austral USA awarded a contract worth up to US$3.195 billion from the US Navy Pushpay ceases trading on the ASX and NZX following its $1.... |
Stockhead | HCT | 2 years ago |
|
Closing Bell: Its a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: Mega gold merger outweighs bankers’ ex-div dive, leaving the ASX up 0.1%
After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike As far as days on the ASX go, that definitely... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: Solid effort from the techies leads a post-lunch recovery to -0.08%
An afternoon rally has put some lead back in the market’s pencil, closing down 0.08%. Tech stocks and Small Ordinaries drive the wins, with InfoTech up 1.5% for the day. Lithium’s back on the menu, with three big names making some chunky,... |
Stockhead | HCT | 2 years ago |
|
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: Nobody’s quite game to pick the bottom after the ASX makes it 5 losses on the trot
ASX waddled to a -0.3% close, like a toddler with a turd in its trousers. Even the goldies retreated, with the XGD ASX All Ords Gold index dropping 0.20%. Blackmores sale is the most exciting thing to happen all day… which says it all, rea... |
Stockhead | HCT | 2 years ago |
|
Closing Bell: ASX sneaks into the green with Mining stocks leading the way
The ASX 200 was up 0.23% while the ASX XEC managed a 0.092% gain 8 out of 11 sectors were higher with Materials leading the way The Real Estate sector was the weakest, down 0.77% The ASX 200 was up 0.23% today while the ASX XEC squeez... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: Be honest. If the Energy sector was a horse right now, you’d shoot it
ASX 200 sinks to -2.2% before recovering to close near -1.5% for the day Energy sector tanks -5.0% because it wants to watch you cry in the shower Low unemployment data sets up the RBA to keep twisting Australia’s nipples, just the way we... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: Who knew you could still make money from inside a burning dumpster?
ASX hammered as bank-driven fear grips the market like a python round a possum XEC Emerging Companies falls more than 2.0% because they’re young and don’t know any better Safe haven goldies still managed to make bank. Sorry… poor choice of... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: And the Oscar for Best Performing Company in a Comedy Drama goes to…
ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0% Looking a... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: Wages data shows Australia making real progress at going backwards
The ASX fell 0.4% after Wall Street was hit by a massive sell-off overnight Wage data shows ‘real wage’ decline in 2022 is the worst in recorded history Toys’R’Us wins the day by offering to buy back its own beleaguered shares And that’... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: If everything could just stop blowing up for a while, that’d be great.
ASX slumps even lower after lunch to end the day down around 0.5% China’s demands for the return of “weather balloon” debris met with hearty Pentagon chuckles Terramin’s bid to reopen a sub-winery mine shut down by the SA government It’... |
Stockhead | HCT | 2 years ago |
|
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care
The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry The US FDA announced last week that:... |
Stockhead | HCT | 2 years ago |
|
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: FTX is complaining that someone keeps stealing ‘their’ money. lol.
Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million The... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: China’s FYQ2 GDP results are more rubbery than a grubby Gold Coast weekend
Adelong Gold cranks out a 143% gain for the day ASX 200 benchmark feel by 0.13% by the close of play China’s December Quarter GDP figures are… let’s just say ‘questionably good at best’ We’ve just got time for a super-quick, lightning-... |
Stockhead | HCT | 2 years ago |
|
CLOSING BELL: It’s never a good idea to let the ASX dress all in red ‘just like Santa Claus’
Good news is bad news for the US economy Aussie benchmark goes deep into a pre-Christmas shame spiral Ho ho oh s%#$! What just happened? The Closing Jingle Bell has rung, so that’s it until after Christmas for 2022! What a pity today’s... |
Stockhead | HCT | 2 years ago |
|
How out of favour Biotech has a PR problem and could learn from Dr Karl
ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and... |
Stockhead | HCT | 3 years ago |
|
Closing Bell: Small caps hold steady while waiting on US midterm results
Small caps up 0.86% while global markets wait for US midterm election results Aussies have hit a record 1 million side hustles as the cost of living rises ReNu Energy nabs $100m investment from superannuation fund for green hydrogen proj... |
Stockhead | HCT | 3 years ago |
|
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month There were 191 ASX IPOs in... |
Stockhead | HCT | 3 years ago |
|
Holista Colltech (ASX:HCT) scaling new heights with milestones across divisions
Highlights Holista Colltech specialises in health and wellness solutions developed using a blend of the best of nature and science. Today, Holista has emerged as a strong player in the US$4.4 trillion global health and wellness industr... |
Kalkine Media | HCT | 3 years ago |
|
Webinar Recap – TD1, MYL, C1X & HCT
ShareCafeWebinar Recap – TD1, MYL, C1X & HCT Catch up on the full webinar presentations from TALi (ASX: TD1), Mallee Resources (ASX: MYL), Cosmos Exploration (ASX: C1X) & Holista Colltech (ASX: HCT) Webinar Recap – TD1, MYL, C1X &a... |
ShareCafe | HCT | 3 years ago |
|
Holista Colltech (ASX: HCT) – Webinar Presentation
ShareCafeHolista Colltech (ASX: HCT) – Webinar Presentation Dr Rajen Manicka – Chairman and CEO – Holista is dedicated to delivering first-class natural ingredients and wellness products, and leads in research on herbs and food ingredients... |
ShareCafe | HCT | 3 years ago |
|
Closing Bell: Small Caps have punched well above their weight today
The ASX 200 is pretty flat, small caps up circa 0.5% Materials and energy dragging locally Alibaba reports tonight: analysts predicting 30 thieves, down from previous high of 40 Around lunchtime, the major banks started passing on the... |
Stockhead | HCT | 3 years ago |
|
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F... |
Stockhead | HCT | 3 years ago |
|
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m... |
Stockhead | HCT | 3 years ago |
|
Top 10 at 10: These ASX stocks are top dogs this morning
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | HCT | 3 years ago |
|
Closing Bell: A lithium leak is draining the small cap battery boom
Emerging markets index closes 2.3% lower ASX200 pretty flat, maybe ahead by 0.1% March Qtr GDP rises 0.8% The Emerging Companies Index has got a lithium leak. We don’t where, we don’t know why. It was down more than 2.7% and has kinda... |
Stockhead | HCT | 3 years ago |
|
Top 10 at 10: The best and worst ASX stocks in early trade
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | HCT | 3 years ago |
|
Closing Bell: Emerging Companies Index stronger, ASX200 weaker on a Chilly Choosday in Sydney
Emerging markets index up 0.5% ASX200 1% lower Belararox (ASX:BRX) rocks The ASX Emerging Companies (XEC) Index was trading 0.6% higher after lunch to the exact degree the ASX200 (XJO) was not, 0.6% weaker. At the close the small cap... |
Stockhead | HCT | 3 years ago |
|
Closing Bell: Small Caps show fine pluck, Galileo takes down flat-earthers
XEC rises like a stubborn mule, up 0.5% XJO wobbles, equivocates somehow ends 0.2% higher Galileo Mining (ASX:GAL) gains circa 200% Choppy trade – oh yes – but with Galileo Mining (ASX:GAL) coming out swinging on Wednesday morning, tha... |
Stockhead | HCT | 3 years ago |
|
Closing Bell: Sinking local markets jump ship as Central Bank prepares to board
Central Banks have their fingers on the fun button this week, and the markets are pricing in the big push. The Emerging Companies Index (XEC) has been sunk on day dot, down 2.3%. The S&P/ASX 200 index was down 1.2% at 4.15pm, with this... |
Stockhead | HCT | 3 years ago |
|
Check Up: Money managers are still bullish on Healthcare; here’s what they said
The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week Dr Anthony Faucci, America’s top infectious disea... |
Stockhead | HCT | 3 years ago |
|
Holista Colltech (ASX:HCT) subsidiary receives first commercial order from Country Farms
Holista Colltech’s (HCT) subsidiary, Holista Biotech, receives its first commercial order from Country Farms for its food ingredients Country Farms has placed a $43,000 order for Holista’s low glycaemic index (GI) food ingredient, GI Lite... |
themarketherald.com.au | HCT | 3 years ago |
|
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot... |
Stockhead | HCT | 3 years ago |
|
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve... |
Stockhead | HCT | 3 years ago |
|
Closing Bell: It looks like Nickel Mines is gonna make it (as small caps survive and thrive)
The ASX Emerging Companies (XEC) index is busting out after a three-session losing streak that felt like ten days. I should know, I spent a week in Canberra one afternoon when I was about 15. Anyway, the index for sensational small caps is... |
Stockhead | HCT | 3 years ago |
|
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month
Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal... |
Stockhead | HCT | 3 years ago |
|
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX
The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby... |
Stockhead | HCT | 3 years ago |
|
Check Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pc
At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform... |
Stockhead | HCT | 3 years ago |
|
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %... |
Stockhead | HCT | 3 years ago |
|
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont... |
Stockhead | HCT | 3 years ago |
|
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M... |
Stockhead | HCT | 4 years ago |
|
Closing Bell: Liontown spinoff Minerals260 shrugs off ASX malaise to shine
Minerals260 (ASX:MI6), a spinoff from Liontown Resources (ASX:LTR), enjoyed a positive debut despite the ASX finishing down again. The ASX 200 retreated 0.26% to close at 7,821 points with all sectors in the red except consumer staples and... |
Stockhead | HCT | 4 years ago |
|
Holista Colltech (ASX:HCT) subsidiary signs term sheet with Country Farms
Holista Colltech’s (HCT) subsidiary signs a non-binding collaboration term sheet with Country Farms Owned by Malaysian conglomerate Berjaya Corporation Berhad, Country Farms operates several franchises of international brands in Malaysia... |
themarketherald.com.au | HCT | 4 years ago |
|
Closing Bell: NSW lockdown ends but market downturn drags on
The ASX retreated again as angst over inflation and the withdrawal of stimulus continued to weigh on global markets. The ASX 200 closed at 7,300 – 0.28% lower than Friday’s close. Tech was the biggest laggard, losing nearly 3% but energy an... |
Stockhead | HCT | 4 years ago |